Eph inhibitor 1
Eph inhibitor 1 is a potent Eph inhibitor. Eph inhibitor 1 has the potential for the research of neurological disorders[1].
Product Specifications
CAS Number
[861249-77-6]
Product Name Alternative
2'-3'-cyclic GMP-AMP (sodium)
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Ephrin Receptor
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/eph-inhibitor-1.html
Purity
99.92
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC1=CC=CC(C2=C(N)N3C(N=C2)=C(C4=CC=CN=C4)C=N3)=C1
Molecular Formula
C17H13N5O
Molecular Weight
303.32
Precautions
H315, H319
References & Citations
[1]Rajeev Sivasan, et al. Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders. WO2007103432A2.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
FHL2 (Four and a Half LIM Domains Protein 2, FHL-2 Protein, Aging Associated Gene 11, AAG11, DRAL, LIM Domain Protein DRAL, Skeletal Muscle LIM Protein 3, SLIM3) (MaxLight 550)
FHL2 (Four and a Half LIM Domains Protein 2, FHL-2 Protein, Aging Associated Gene 11, AAG11, DRAL, LIM Domain Protein DRAL, Skeletal Muscle LIM Protein 3, SLIM3) (MaxLight 550)
Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3, Fms-like Tyrosine Kinase 4, FLT-4, Tyrosine-protein Kinase Receptor FLT4, Flt4, Flt-4)(APC)
Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3, Fms-like Tyrosine Kinase 4, FLT-4, Tyrosine-protein Kinase Receptor FLT4, Flt4, Flt-4)(APC)